These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20725134)

  • 21. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased activity of endogenous endothelin in patients with type II diabetes mellitus.
    Cardillo C; Campia U; Bryant MB; Panza JA
    Circulation; 2002 Oct; 106(14):1783-7. PubMed ID: 12356630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endothelin in the increased vascular tone of patients with essential hypertension.
    Cardillo C; Kilcoyne CM; Waclawiw M; Cannon RO; Panza JA
    Hypertension; 1999 Feb; 33(2):753-8. PubMed ID: 10024340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
    Böhm F; Ahlborg G; Pernow J
    Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White blood cell count and endothelin-1 vasoconstrictor tone in middle-aged and older adults.
    Diehl KJ; Weil BR; Greiner JJ; Stauffer BL; Desouza CA
    Artery Res; 2012 Jun; 6(2):65-70. PubMed ID: 23908675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerobic exercise training reduces ET-1-mediated vasoconstriction and improves endothelium-dependent vasodilation in postmenopausal women.
    Wenner MM; Welti LM; Dow CA; Greiner JJ; Stauffer BL; DeSouza CA
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H732-H738. PubMed ID: 36961490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
    Just A; Olson AJ; Arendshorst WJ
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
    D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.
    Campia U; Cardillo C; Panza JA
    Circulation; 2004 Jun; 109(25):3191-5. PubMed ID: 15148269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
    Awane-Igata Y; Ikeda S; Watanabe T
    Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearm.
    Rab A; Dallinger S; Polak K; Pleiner J; Polska E; Wolzt M; Schmetterer L
    J Pharmacol Exp Ther; 2004 May; 309(2):692-6. PubMed ID: 14757848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm.
    Berrazueta JR; Bhagat K; Vallance P; MacAllister RJ
    Br J Clin Pharmacol; 1997 Dec; 44(6):569-71. PubMed ID: 9431833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevations in C-reactive protein and endothelin-1 system activity in humans.
    Dow CA; Templeton DL; Lincenberg GM; Greiner JJ; Stauffer BL; DeSouza CA
    Life Sci; 2016 Aug; 159():66-70. PubMed ID: 26685760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.
    Cardillo C; Campia U; Iantorno M; Panza JA
    Hypertension; 2004 Jan; 43(1):36-40. PubMed ID: 14656951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans.
    McEniery CM; Wilkinson IB; Jenkins DG; Webb DJ
    Hypertension; 2002 Aug; 40(2):202-6. PubMed ID: 12154114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
    Oechslin E; Kiowski W; Schindler R; Bernheim A; Julius B; Brunner-La Rocca HP
    Circulation; 2005 Aug; 112(8):1106-12. PubMed ID: 16103236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
    Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased activity of endogenous endothelin in patients with hypercholesterolemia.
    Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
    J Am Coll Cardiol; 2000 Nov; 36(5):1483-8. PubMed ID: 11079646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.